Blueprint Presents Proof-of-Concept Data of BLU-945 in P-I/II (SYMPHONY) Trial for EGFR-Mutant Non-Small Cell Lung Cancer at AACR...
April 11, 2022
Blueprint Collaborated with Proteovant to Advance Novel Targeted Protein Degrader Therapies
March 1, 2022
PharmaShots Weekly Snapshots (July 13- 17, 2020)
July 20, 2020
Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20
June 1, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.